Cargando…

Review of Intraoperative Adjuncts for Maximal Safe Resection of Gliomas and Its Impact on Outcomes

SIMPLE SUMMARY: Understanding the impact of intraoperative modalities in glioma surgery on the extent of resection (EOR), survival, and complications is vital to maximizing safe resection while preserving neurological function. A systematic literature search was performed to assess the impact of int...

Descripción completa

Detalles Bibliográficos
Autores principales: Chanbour, Hani, Chotai, Silky
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688206/
https://www.ncbi.nlm.nih.gov/pubmed/36428797
http://dx.doi.org/10.3390/cancers14225705
_version_ 1784836209000841216
author Chanbour, Hani
Chotai, Silky
author_facet Chanbour, Hani
Chotai, Silky
author_sort Chanbour, Hani
collection PubMed
description SIMPLE SUMMARY: Understanding the impact of intraoperative modalities in glioma surgery on the extent of resection (EOR), survival, and complications is vital to maximizing safe resection while preserving neurological function. A systematic literature search was performed to assess the impact of intraoperative modalities of glioma surgery, including one or a combination of the following: intraoperative magnetic resonance imaging (iMRI), awake/general anesthesia craniotomy mapping (AC/GA), fluorescence-guided imaging, or combined modalities. The heterogeneity in reporting the amount of surgical resection prevented further analysis. The studies reviewed indicated that these modalities significantly improved EOR but most often underreported Progression-free survival/overall survival (PFS/OS). Combining intraoperative modalities during the same brain glioma operation seems to have the highest effect compared to each modality alone. ABSTRACT: Maximal safe resection is the mainstay of treatment in the neurosurgical management of gliomas, and preserving functional integrity is linked to favorable outcomes. How these modalities differ in their effectiveness on the extent of resection (EOR), survival, and complications remains unknown. A systematic literature search was performed with the following inclusion criteria: published between 2005 and 2022, involving brain glioma surgery, and including one or a combination of intraoperative modalities: intraoperative magnetic resonance imaging (iMRI), awake/general anesthesia craniotomy mapping (AC/GA), fluorescence-guided imaging, or combined modalities. Of 525 articles, 464 were excluded and 61 articles were included, involving 5221 glioma patients, 7(11.4%) articles used iMRI, 21(36.8%) used cortical mapping, 15(24.5%) used 5-aminolevulinic acid (5-ALA) or fluorescein sodium, and 18(29.5%) used combined modalities. The heterogeneity in reporting the amount of surgical resection prevented further analysis. Progression-free survival/overall survival (PFS/OS) were reported in 18/61(29.5%) articles, while complications and permanent disability were reported in 38/61(62.2%) articles. The reviewed studies demonstrate that intraoperative adjuncts such as iMRI, AC/GA mapping, fluorescence-guided imaging, and a combination of these modalities improve EOR. However, PFS/OS were underreported. Combining multiple intraoperative modalities seems to have the highest effect compared to each adjunct alone.
format Online
Article
Text
id pubmed-9688206
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96882062022-11-25 Review of Intraoperative Adjuncts for Maximal Safe Resection of Gliomas and Its Impact on Outcomes Chanbour, Hani Chotai, Silky Cancers (Basel) Review SIMPLE SUMMARY: Understanding the impact of intraoperative modalities in glioma surgery on the extent of resection (EOR), survival, and complications is vital to maximizing safe resection while preserving neurological function. A systematic literature search was performed to assess the impact of intraoperative modalities of glioma surgery, including one or a combination of the following: intraoperative magnetic resonance imaging (iMRI), awake/general anesthesia craniotomy mapping (AC/GA), fluorescence-guided imaging, or combined modalities. The heterogeneity in reporting the amount of surgical resection prevented further analysis. The studies reviewed indicated that these modalities significantly improved EOR but most often underreported Progression-free survival/overall survival (PFS/OS). Combining intraoperative modalities during the same brain glioma operation seems to have the highest effect compared to each modality alone. ABSTRACT: Maximal safe resection is the mainstay of treatment in the neurosurgical management of gliomas, and preserving functional integrity is linked to favorable outcomes. How these modalities differ in their effectiveness on the extent of resection (EOR), survival, and complications remains unknown. A systematic literature search was performed with the following inclusion criteria: published between 2005 and 2022, involving brain glioma surgery, and including one or a combination of intraoperative modalities: intraoperative magnetic resonance imaging (iMRI), awake/general anesthesia craniotomy mapping (AC/GA), fluorescence-guided imaging, or combined modalities. Of 525 articles, 464 were excluded and 61 articles were included, involving 5221 glioma patients, 7(11.4%) articles used iMRI, 21(36.8%) used cortical mapping, 15(24.5%) used 5-aminolevulinic acid (5-ALA) or fluorescein sodium, and 18(29.5%) used combined modalities. The heterogeneity in reporting the amount of surgical resection prevented further analysis. Progression-free survival/overall survival (PFS/OS) were reported in 18/61(29.5%) articles, while complications and permanent disability were reported in 38/61(62.2%) articles. The reviewed studies demonstrate that intraoperative adjuncts such as iMRI, AC/GA mapping, fluorescence-guided imaging, and a combination of these modalities improve EOR. However, PFS/OS were underreported. Combining multiple intraoperative modalities seems to have the highest effect compared to each adjunct alone. MDPI 2022-11-21 /pmc/articles/PMC9688206/ /pubmed/36428797 http://dx.doi.org/10.3390/cancers14225705 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Chanbour, Hani
Chotai, Silky
Review of Intraoperative Adjuncts for Maximal Safe Resection of Gliomas and Its Impact on Outcomes
title Review of Intraoperative Adjuncts for Maximal Safe Resection of Gliomas and Its Impact on Outcomes
title_full Review of Intraoperative Adjuncts for Maximal Safe Resection of Gliomas and Its Impact on Outcomes
title_fullStr Review of Intraoperative Adjuncts for Maximal Safe Resection of Gliomas and Its Impact on Outcomes
title_full_unstemmed Review of Intraoperative Adjuncts for Maximal Safe Resection of Gliomas and Its Impact on Outcomes
title_short Review of Intraoperative Adjuncts for Maximal Safe Resection of Gliomas and Its Impact on Outcomes
title_sort review of intraoperative adjuncts for maximal safe resection of gliomas and its impact on outcomes
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688206/
https://www.ncbi.nlm.nih.gov/pubmed/36428797
http://dx.doi.org/10.3390/cancers14225705
work_keys_str_mv AT chanbourhani reviewofintraoperativeadjunctsformaximalsaferesectionofgliomasanditsimpactonoutcomes
AT chotaisilky reviewofintraoperativeadjunctsformaximalsaferesectionofgliomasanditsimpactonoutcomes